Aspen Pharmacare (OTCMKTS:APNHY) Trading Down 1.8% - Here's Why

Key Points

• Aspen Pharmacare's shares were down 1.8% during mid-day trading, closing at $6.25 after trading as low as $6.25, marking a decline from the previous close of $6.37.
• Trading volume fell to approximately 187 shares, representing a 67% decrease compared to the average daily volume of 563 shares.
• The company's financial metrics include a quick ratio of 1.25 and a debt-to-equity ratio of 0.36, indicating a stable liquidity position and low leverage.

Shares of Aspen Pharmacare (OTCMKTS:APNHY - ) were down 1.8% during mid-day trading on Monday . The stock traded as low as $6.25 and last traded at $6.25. Approximately 187 shares traded hands during mid-day trading, a decline of 67% from the average daily volume of 563 shares. The stock had previously closed at $6.37.

Aspen Pharmacare Trading Down 1.8%

The company has a quick ratio of 1.25, a current ratio of 2.35 and a debt-to-equity ratio of 0.36. The firm's fifty day moving average is $6.59 and its 200-day moving average is $7.61.

Aspen Pharmacare Company Profile

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.